Evolent Health, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Evolent Health, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2013 to 2023.
  • Evolent Health, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $14.9M, a 96.1% decline year-over-year.
  • Evolent Health, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $281M, a 114% increase from 2022.
  • Evolent Health, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $132M.
  • Evolent Health, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was -$29.5M, a 149% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $281M +$150M +114% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-23
2022 $132M +$161M Jan 1, 2022 Dec 31, 2022 10-K 2024-02-23
2021 -$29.5M -$17.7M -149% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-23
2020 -$11.9M +$23.7M +66.6% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-24
2019 -$35.5M -$310M -113% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 $274M +$108M +65.5% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-26
2017 $166M +$15.4M +10.2% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-02
2016 $150M -$64M -29.9% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 $214M +$214M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-01
2014 $0 -$34.3M -100% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-03
2013 $34.3M Jan 1, 2013 Dec 31, 2013 10-K 2016-02-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.